Active Materials

Scientists at George Mason University’s Center for Applied Proteomics and Molecular Medicine have invented an innovative nanotechnology tool that may lead to a dramatic improvement in treatment results for patients diagnosed with cancer or other diseases. The novel diagnostic tool is uniquely suited for the discovery of new protein biomarkers in the blood that provide sensitive and specific disease detection at the earliest stage when treatment is most effective. More here